Search

everythinglearnresearchcommunity

for

Search:↓

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Certain genes control the color of human hair by affecting pigment production.

Follistatin helps hair growth and cycling, while activin prevents it.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Wnt10b overexpression can regenerate hair follicles, possibly helping treat hair loss and alopecia.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

TPA is about 50 times more effective at promoting tumors than MZ.

Sophora flavescens extract may help hair grow by affecting growth factors and blocking a hair-related enzyme.

TRH stimulates human hair growth and extends the hair growth phase.

HFMs can help study hair growth and test potential hair growth drugs.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Light can turn on hair growth cells through a nerve path starting in the eyes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.